Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2058 to 2107 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2058\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L11. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.609415\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.65323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229687965\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPL11\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2059\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S15A. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.672841\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.92963\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229667569\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RPS15A\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2060\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN CGI-27 (C21ORF19-LIKE PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.390544\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.70053\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229660165\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MEMO1P\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2061\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLYCEROL-3-PHOSPHATE DEHYDROGENASE [NAD+], CYTOPLASMIC (EC 1.1.1.8) (GPD-C) (GPDH-C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.1548\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.674093\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229641904\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GPD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2062\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASE REGULATORY SUBUNIT 8 (PROTEASOME SUBUNIT P45) (THYROID HORMONE RECEPTOR INTERACTING PROTEIN 1) (TRIP1) (MSUG1 PROTEIN) (TAT-BINDING PROTEIN HOMOLOG 10) (TBP10) (P45/SUG). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.476629\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.07581\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229611092\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMC5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2063\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BECLIN 1 (COILED-COIL MYOSIN-LIKE BCL2-INTERACTING PROTEIN) (PROTEIN GT197). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0471781\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.20547\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229610649\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BECN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2064\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.134261\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.584848\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229565631\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GPD1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2065\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOSIDE DIPHOSPHATE KINASE 3 (EC 2.7.4.6) (NDK 3) (NDP KINASE 3) (NM23-H3) (DR-NM23). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.366443\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.59695\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229464291\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NME3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2066\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"60 KDA HEAT SHOCK PROTEIN, MITOCHONDRIAL PRECURSOR (HSP60) (60 KDA CHAPERONIN) (CPN60) (HEAT SHOCK PROTEIN 60) (HSP-60) (MITOCHONDRIAL MATRIX PROTEIN P1) (P60 LYMPHOCYTE PROTEIN) (HUCHA60). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.16919\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.737338\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229460573\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HSPD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2067\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAS-RELATED PROTEIN RAB-26. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.016721\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0728736\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229452092\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RAB26\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2068\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAS-RELATED PROTEIN RAB-37. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0208556\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0908932\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229451708\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RAB37\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2069\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0584321\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.25466\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229451425\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZCCHC4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2070\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-DIRECTED RNA POLYMERASE II 33 KDA POLYPEPTIDE (EC 2.7.7.6) (RPB3) (RNA POLYMERASE II SUBUNIT 3) (RPB33) (RPB31). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.60424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6.99164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229451173\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
POLR2C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2071\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"AMINOMETHYLTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.1.2.10) (GLYCINE CLEAVAGE SYSTEM T PROTEIN) (GCVT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.130784\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.569999\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229446017\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AMT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2072\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"28S RIBOSOMAL PROTEIN S9, MITOCHONDRIAL PRECURSOR (MRP-S9). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.640883\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.79379\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229395552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRPS9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2073\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
N-ACETYLGLUTAMATE SYNTHASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.517899\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.25773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229389254\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NAGS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2074\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL RECOGNITION PARTICLE RECEPTOR ALPHA SUBUNIT (SR-ALPHA) (DOCKING PROTEIN ALPHA) (DP-ALPHA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.411592\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.79509\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229287668\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2075\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIKELY ORTHOLOG OF MOUSE VARIANT POLYADENYLATION PROTEIN CSTF-64. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.388695\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.69606\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229175265\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSTF2T\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2076\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PREFOLDIN SUBUNIT 5 (C-MYC BINDING PROTEIN MM-1) (MYC MODULATOR 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.299475\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.30706\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229121081\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PFDN5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2077\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PREFOLDIN SUBUNIT 6 (PROTEIN KE2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.027225\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.118824\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22912038\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2078\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM/HOMEOBOX PROTEIN LHX4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.374874\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.63637\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229088776\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LHX4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2079\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM DOMAIN BINDING 1; CARBOXY TERMINAL LIM DOMAIN PROTEIN 2; LIM DOMAIN-BINDING FACTOR-1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0979801\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.427723\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229073723\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2080\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM DOMAIN BINDING 2; LIM BINDING DOMAIN 2; LIM DOMAIN-BINDING FACTOR-2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0881768\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.384928\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229073489\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LDB2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2081\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0966625\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.421972\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229073256\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C6orf153\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2082\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM/HOMEOBOX PROTEIN LHX3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.451026\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.96903\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229059994\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LHX3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2083\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CAD PROTEIN [INCLUDES: GLUTAMINE-DEPENDENT CARBAMOYL-PHOSPHATE SYNTHASE (EC 6.3.5.5); ASPARTATE CARBAMOYLTRANSFERASE (EC 2.1.3.2); DIHYDROOROTASE (EC 3.5.2.3)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.341867\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.49271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229024392\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAD\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2084\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S29. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.477897\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.0867\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.229020463\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2085\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUVB-LIKE 1 (EC 3.6.1.-) (49-KDA TATA BOX-BINDING PROTEIN-INTERACTING PROTEIN) (49 KDA TBP-INTERACTING PROTEIN) (TIP49A) (PONTIN 52) (NUCLEAR MATRIX PROTEIN 238) (NMP 238) (54 KDA ERYTHROCYTE CYTOSOLIC PROTEIN) (ECP-54) (TIP60-ASSOCIATED PROTEIN 54-ALPHA)\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.185296\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.809316\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228953833\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RUVBL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2086\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLUTAMATE DEHYDROGENASE 2, MITOCHONDRIAL PRECURSOR (EC 1.4.1.3) (GDH). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.149641\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.654219\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.228732275\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
GLUD2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2087\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLUTAMATE DEHYDROGENASE 1, MITOCHONDRIAL PRECURSOR (EC 1.4.1.3) (GDH). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
GLUDP5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2088\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.031325\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.13696\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228716414\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2089\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC42 GUANINE EXCHANGE FACTOR 9; HPEM-2 COLLYBISTIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0307532\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.13446\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228716347\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGEF9\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2090\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEOPORIN LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.21824\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.954199\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228715394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUPL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2091\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 4 ISOFORM A; APC-STIMULATED GUANINE NUCLEOTIDE EXCHANGE FACTOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0362539\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.158511\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228715357\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGEF4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2092\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"NADPH:ADRENODOXIN OXIDOREDUCTASE, MITOCHONDRIAL PRECURSOR (EC 1.18.1.2) (ADRENODOXIN REDUCTASE) (AR) (FERREDOXIN-NADP(+) REDUCTASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0601271\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.262913\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228695804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FDXR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2093\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"2-OXOGLUTARATE DEHYDROGENASE E1 COMPONENT, MITOCHONDRIAL PRECURSOR (EC 1.2.4.2) (ALPHA-KETOGLUTARATE DEHYDROGENASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.313207\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.36954\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228695036\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OGDH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2094\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.282831\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.23673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228692601\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2095\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SYMPLEKIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0685085\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.299686\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228600936\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SYMPK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2096\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SIGNAL TRANSDUCING ADAPTOR MOLECULE 2; STAM-LIKE PROTEIN CONTAINING SH3 AND ITAM DOMAINS 2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.337171\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.47582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228463498\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STAM2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2097\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
URIDINE KINASE-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.180388\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.789739\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228414704\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2098\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLUTATHIONE REDUCTASE, MITOCHONDRIAL PRECURSOR (EC 1.8.1.7) (GR) (GRASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.453634\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.98642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228367616\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GSR\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2099\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CYTOCHROME C OXIDASE SUBUNIT IV ISOFORM 2, MITOCHONDRIAL PRECURSOR (EC 1.9.3.1) (COX IV-2). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0360136\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.15771\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.228353307\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
COX4I2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2100\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE B PRECURSOR (EC 5.2.1.8) (PPIASE) (ROTAMASE) (CYCLOPHILIN B) (S-CYCLOPHILIN) (SCYLP) (CYP-S1). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PPIB\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2101\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CYTOCHROME C OXIDASE SUBUNIT IV ISOFORM 1, MITOCHONDRIAL PRECURSOR (EC 1.9.3.1) (COX IV-1) (CYTOCHROME C OXIDASE POLYPEPTIDE IV). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
COX4I1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2102\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0653467\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.286165\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228353223\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
INTS8\vspace{3pt}}\\\cline{1-1}\cline{3-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2103\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0653647\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.286244\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.228353083\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
GON4L\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROTEIN KINASE C, EPSILON TYPE (EC 2.7.1.-) (NPKC-EPSILON). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
PRKCE\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2105\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UDP-N-ACETYLGLUCOSAMINE--PEPTIDE N-ACETYLGLUCOSAMINYLTRANSFERASE 110 KDA SUBUNIT (EC 2.4.1.-) (O-GLCNAC TRANSFERASE P110 SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.173405\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.759373\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228352865\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OGT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2106\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROTEIN KINASE C, ETA TYPE (EC 2.7.1.-) (NPKC-ETA) (PKC-L). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0507599\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.222289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228350931\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PRKCH\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2107\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0325606\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.142608\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.228322394\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FBXO42\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/